注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Vaxcyte Inc是一家临床阶段疫苗公司,专注于开发疫苗,以保护人类免受细菌性疾病的影响。该公司的生产线包括肺炎球菌结合疫苗(PCV)、VAX-24、VAX-XP、VAX-A1和VAX-PG。该公司的候选PCV正在开发中,目标是全球肺炎球菌疫苗市场。该公司的主要候选疫苗VAX-24是一种24价、广谱的PCV,用于预防侵袭性肺炎球菌病(IPD)和肺炎。该公司的PCV候选者VAX-XP利用其可扩展和模块化平台,并以VAX-24建立的技术概念验证为基础。VAX-A1是一种新型的结合疫苗候选者,旨在预防a组链球菌普遍性疾病。VAX-PG是一种新型蛋白疫苗候选疫苗,针对牙周炎和慢性口腔炎症的关键病原体。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Grant E. Pickering | 54 | 2013 | Co-Founder, CEO & Director |
Carlos V. Paya | 63 | 2021 | Independent Chairman of the Board |
Anthony W. Ford-Hutchinson | - | - | Member of Scientific Advisory Board |
Peter K. Hirth | 70 | 2016 | Independent Director |
Thomas P. Monath | 81 | - | Member of Scientific Advisory Board |
Jeffrey Almond | - | 2017 | Member of Scientific Advisory Board |
Teri Loxam | 50 | 2021 | Independent Director |
Annie Seibold Drapeau | 55 | 2021 | Independent Director |
Halley E. Gilbert | 52 | 2020 | Independent Director |
Heath Lukatch | 55 | 2018 | Independent Director |
Emmanuel Hanon | - | - | Member of Scientific Advisory Board |
Emmanuel Walter | - | - | Member of Scientific Advisory Board |
William Hausdorff | - | - | Member of Scientific Advisory Board |
Jacks Lee | 60 | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核